Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belumosudil in Moderate/Severe Chronic Plaque Psoriasis
NCT02852967Phase 2Completed
- Sponsor
- Kadmon
- Start
- Sep 2016
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of belumosudil in psoriasis, sponsored by Kadmon. Started Sep 2016; status: completed.
02
Drugs
belumosudil
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02852967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02852967.